• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性缺血性脑卒中的静脉溶栓治疗。

Intravenous thrombolysis for acute ischemic stroke.

机构信息

Stroke unit, Sainte-Anne hospital, 1, rue Cabanis, 75014 Paris, France; Université Paris Descartes, Sorbonne Paris Cité, France; Inserm UMR S894, France.

Stroke unit, Sainte-Anne hospital, 1, rue Cabanis, 75014 Paris, France; Université Paris Descartes, Sorbonne Paris Cité, France.

出版信息

Diagn Interv Imaging. 2014 Dec;95(12):1129-33. doi: 10.1016/j.diii.2014.10.002. Epub 2014 Nov 15.

DOI:10.1016/j.diii.2014.10.002
PMID:25465121
Abstract

Intravenous thrombolysis (IVT) with alteplase remains the standard treatment for acute ischemic stroke. Although IVT can be started up to 4.5 hours after symptoms' onset, it is all the more effective and safe when started early. It allows a 10% absolute reduction in the risk of handicap or death at 3 months, despite a 2-7% risk of symptomatic intracranial hemorrhage. Current research efforts involve firstly trying to treat a larger proportion of patients by overcoming some of the contraindications to IVT and secondly assessing combined or alternative treatments to achieve a higher early recanalization rate.

摘要

静脉溶栓(IVT)联合阿替普酶仍然是急性缺血性脑卒中的标准治疗方法。尽管 IVT 可以在症状发作后 4.5 小时内开始,但早期开始治疗效果更好且更安全。尽管存在 2-7%的症状性颅内出血风险,但 IVT 治疗可以使 3 个月时残疾或死亡的风险降低 10%。目前的研究工作首先涉及通过克服 IVT 的一些禁忌证来尝试治疗更大比例的患者,其次评估联合或替代治疗以实现更高的早期再通率。

相似文献

1
Intravenous thrombolysis for acute ischemic stroke.急性缺血性脑卒中的静脉溶栓治疗。
Diagn Interv Imaging. 2014 Dec;95(12):1129-33. doi: 10.1016/j.diii.2014.10.002. Epub 2014 Nov 15.
2
Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial.急性缺血性脑卒中的动脉内溶栓或静脉溶栓?SYNTHESIS 试验的预试验。
J Neurointerv Surg. 2010 Mar;2(1):74-9. doi: 10.1136/jnis.2009.001388. Epub 2009 Oct 30.
3
Thrombolysis for acute ischemic stroke.急性缺血性脑卒中的溶栓治疗。
J Vasc Surg. 2011 Sep;54(3):901-7. doi: 10.1016/j.jvs.2011.04.062.
4
Intravenous Thrombolysis and Passes of Thrombectomy as Predictors for Endovascular Revascularization in Ischemic Stroke.静脉溶栓和血栓切除术次数作为缺血性卒中血管内再灌注治疗的预测因素
J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2488-95. doi: 10.1016/j.jstrokecerebrovasdis.2016.06.024. Epub 2016 Aug 2.
5
Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.急性缺血性脑卒中发病后 3-4.5 小时的溶栓治疗-来自加拿大阿替普酶治疗脑卒中有效性研究(CASES)登记研究的证据。
Cerebrovasc Dis. 2011;31(3):223-8. doi: 10.1159/000321893. Epub 2010 Dec 21.
6
SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.SYNTHESIS 扩张:一项非营利性、务实性、随机对照试验的设计,比较最佳快速血管内治疗与标准静脉内阿替普酶治疗急性缺血性卒中。
Int J Stroke. 2011 Jun;6(3):259-65. doi: 10.1111/j.1747-4949.2011.00587.x. Epub 2011 Mar 18.
7
CT-based intravenous thrombolysis 3-4.5 hours after acute ischemic stroke in clinical practice.临床实践中急性缺血性卒中发病3 - 4.5小时后基于CT的静脉溶栓治疗。
Neurol Res. 2011 Sep;33(7):701-7. doi: 10.1179/1743132811Y.0000000002.
8
Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.当前恶性肿瘤患者急性缺血性脑卒中溶栓治疗的风险。
J Stroke Cerebrovasc Dis. 2011 Mar-Apr;20(2):124-30. doi: 10.1016/j.jstrokecerebrovasdis.2009.10.010. Epub 2010 Jul 3.
9
[Thrombolytic therapy in acute ischemic stroke. Critical analysis of current knowledge].[急性缺血性卒中的溶栓治疗。对当前知识的批判性分析]
Lakartidningen. 2004 Feb 19;101(8):662-8, 670-3.
10
Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.年龄较大并不会增加急性卒中静脉和/或动脉内溶栓后出血并发症的风险。
J Stroke Cerebrovasc Dis. 2008 Sep;17(5):266-72. doi: 10.1016/j.jstrokecerebrovasdis.2008.03.003.

引用本文的文献

1
Value of intravenous alteplase before thrombectomy among patients with tandem lesions and emergent carotid artery stenting: A subgroup analysis of the SWIFT DIRECT trial.静脉注射阿替普酶溶栓治疗在串联病变且紧急颈动脉支架置入术患者中的价值:SWIFT DIRECT 试验的亚组分析。
Eur J Neurol. 2024 Jun;31(6):e16256. doi: 10.1111/ene.16256. Epub 2024 Feb 26.
2
Neuroimaging Markers of Cerebral Small Vessel Disease on Hemorrhagic Transformation and Functional Outcome After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.急性缺血性脑卒中患者静脉溶栓后出血转化及功能结局的脑小血管病神经影像学标志物:一项系统评价和荟萃分析
Front Aging Neurosci. 2021 Jul 13;13:692942. doi: 10.3389/fnagi.2021.692942. eCollection 2021.
3
Predictive Factors for Functional Outcomes After Intravenous Thrombolytic Therapy in Acute Ischemic Stroke.急性缺血性脑卒中静脉溶栓治疗后功能结局的预测因素。
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):171S-177S. doi: 10.1177/1076029618796317. Epub 2018 Sep 13.